MEDICINOVA, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
MEDICINOVA, INC. (MNOV) had Lessee, Operating Lease, Liability, to be Paid, Year One of $17.27 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-13
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $17.27K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $17.27K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $206.48K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $206.48K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $17.27K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $17.27K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $206.48K 10-K · filed 2026-03-10 |
| 2025-09-30 | $206.48K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $206.48K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $206.48K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $224.06K 10-K · filed 2025-02-19 |
| 2024-09-30 | $226.65K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $223.40K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $227.30K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $265.70K 10-K · filed 2024-02-15 |
| 2023-09-30 | $261.42K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $263.81K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $189.17K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $216.15K 10-K/A · filed 2023-03-28 |
| 2022-09-30 | $63.07K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $127.49K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $168.85K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $210.82K 10-K · filed 2022-02-16 |
| 2021-09-30 | $61.97K 10-Q · filed 2021-11-12 |
| 2020-12-31 | $192.56K 10-K · filed 2021-02-19 |
| 2019-12-31 | $243.31K 10-K · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |